DUBLIN, August 4, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global - Adult Vaccines Market - Company Analysis and Forecast to 2021" report to their offering.
The adult vaccines market has been forecasted to increase at a compound annual growth rate (CAGR) of around 6% over the next five years. Adults are as likely as children to die from diseases that they can be immunized. For example, vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related complications in the elderly. Adult vaccines continue to be one of the growing segment for pharmaceutical companies. The driving factors for adult vaccines growth are an increasing acceptance of adult vaccines and the public health focus on flu prevention, as well as introductions of new vaccines. The vaccines industry also faces hindrances such as vaccine safety, shortages and delays, vaccine development time line as well as entry barriers for new manufacturers.
Adult Vaccines Market - Disease Wise Analysis
The influenza vaccines capture maximum share of the total adult vaccines market. It is the most popular and accepted vaccination amongst adults. The hepatitis vaccines account for second highest share of the total adult vaccines market in 2015. The HPV/cervical cancer vaccines and pneumococcal vaccines captures the third and fourth highest share of the adult vaccines market respectively in 2015. While vaccines for zoster shingles and DTP are also gaining ground in adult vaccines market landscape.
Adult Vaccines Market - Disease Wise Company Sales Analysis
GSK generates maximum adult vaccines sales from Hepatitis and DTP vaccines, while Sanofi Pasteur remains focused on maintaining its leadership in the influenza vaccines market. The cervical cancer and zoster shingles vaccines contributes maximum share of the total Merck adult vaccines sales. Novartis main source of adult vaccines sales revenue is the influenza vaccines.
In 2011, Sanofi Pasteur replaced GSK and became the dominant player in the influenza vaccines landscape, while in the cervical cancer vaccines market, Merck is at the forefront and is expected to maintain its dominancy over a longer period of time. GSK is the clear leader in hepatitis vaccines market.
Adult Vaccines Market - Regional Distribution
On a regional basis, the United States comprises the single largest market for adult vaccines being closely followed by Europe. Japan's adult vaccines market share is expected to remain flat during the forecasting period, while China's adult vaccines market is likely to show continuous growth. South America and India are competing closely with each other to grab maximum share of the adult vaccines market pie.
The 9 Diseases covered in the report are analyzed from four viewpoints:
1. Adult Vaccines Market (2007 - 2021)
2. Number of Adults Vaccinated (2007 - 2021)
3. Number of Doses (2007 - 2021)
4. Company Sales Share (2010 - 2021)
The 7 Companies covered in the report are analyzed from two viewpoints:
1. Disease Wise - Adult Vaccines Sales (2007 - 2021)
2. Strategic Alliances
Global Adult Vaccines Market, Number of Adults Vaccinated and Doses - Disease Wise Analysis to 2021 (9 Disease Analysed)
2. Cervical Cancer
3. Zoster Shingles
9. Travel and Miscellaneous
Key Topics Covered:
1. Executive Summary
2. Global - Adult Vaccines Analysis and Forecast (2007 - 2021)
3. Global Adult Vaccine Market Share Analysis and Forecast (2010 - 2021)
4. Global Adult Vaccine Market - Disease Wise Analysis
5. Global Adult Vaccine Market - Company Analysis and Strategic Alliances
6. Global Adult Vaccine - Disease Wise Company Sales and Forecast (2007 - 2021)
7. Global Adult Vaccine Market - Regional Distribution (2011 - 2021)
8. Major Vaccine Related Acquisitions (2005-2015)
9. Adult Vaccines Market - Driving Factors
10. Adult Vaccines Market - Challenges
- Protein Sciences
- Sanofi Pasteur
For more information visit http://www.researchandmarkets.com/research/fvbppv/global_adult
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-adult-vaccines-company-analysis-and-forecast-2007-2021---research-and-markets-300309293.html
SOURCE Research and Markets